Literature DB >> 3376975

Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass.

D E Salazar1, G B Corcoran.   

Abstract

Existing methods for predicting creatinine clearance provide accurate estimates for normal-weight patients but not for patients who are obese. Studies into this problem began with an animal model of obesity, the obese overfed rat. Mean creatinine clearance was found to vary in direct proportion to fat-free body mass, determined in both obese and normal animals. The relevance of this observation to renal function in humans was evaluated by analyzing published studies reporting creatinine clearance and creatinine excretion rates in obese and normal persons. Measured creatinine clearance correlated well with estimated fat-free body mass (r = 0.772, p less than 0.02), and urinary excretion of creatinine normalized to fat-free mass correlated impressively with age (r = 0.960). Formulas derived from these observations allow for the prediction of creatinine clearance at steady state: (formula; see text) In initial tests of these formulas, their predictions appeared to be as accurate as existing methods for the normal-weight population and far superior to these methods when applied to the obese population. Therefore, when creatinine clearance is not measured in obese patients, the estimation of this parameter with the proposed formulas should improve the ability to select the appropriate dose for drugs that are cleared principally by renal filtration.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3376975     DOI: 10.1016/0002-9343(88)90310-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  65 in total

Review 1.  Effects of obesity on pharmacokinetics implications for drug therapy.

Authors:  G Cheymol
Journal:  Clin Pharmacokinet       Date:  2000-09       Impact factor: 6.447

2.  Estimation of creatinine clearance from serum creatinine: utility of the Cockroft and Gault equation in Nigerian patients.

Authors:  A A Ajayi
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Pharmacokinetics of moxifloxacin in patients with severe sepsis or septic shock.

Authors:  Mathias W Pletz; Frank Bloos; Olaf Burkhardt; Frank M Brunkhorst; Stefanie M Bode-Böger; Jens Martens-Lobenhoffer; Mark W Greer; Heino Stass; Tobias Welte
Journal:  Intensive Care Med       Date:  2010-03-25       Impact factor: 17.440

Review 4.  Accurate measurement of individual glomerular filtration rate in cancer patients: an ongoing challenge.

Authors:  Karin Holweger; Carsten Bokemeyer; Hans-Peter Lipp
Journal:  J Cancer Res Clin Oncol       Date:  2005-10-20       Impact factor: 4.553

5.  Accuracy of GFR estimation by the Cockroft and Gault, MDRD, and Wright equations in Oncology patients with renal impairment.

Authors:  O O Faluyi; S P Masinghe; R L Hayward; S Clive
Journal:  Med Oncol       Date:  2011-02-01       Impact factor: 3.064

6.  Predicting genitourinary toxicity in patients receiving cisplatin-based combination chemotherapy: a Cancer and Leukemia Group B study.

Authors:  J B Hargis; J R Anderson; K J Propert; M R Green; D A Van Echo; R B Weiss
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

7.  Performance of the Cockcroft-Gault and MDRD equations in adult Nigerians with chronic kidney disease.

Authors:  Emmanuel I Agaba; Chinyere M Wigwe; Patricia A Agaba; Antonios H Tzamaloukas
Journal:  Int Urol Nephrol       Date:  2009-01-10       Impact factor: 2.370

8.  Impact of Weight Extremes on Clinical Outcomes in Pediatric Acute Respiratory Distress Syndrome.

Authors:  Shan L Ward; Virginia Gildengorin; Stacey L Valentine; Anil Sapru; Martha A Q Curley; Neal Thomas; Douglas F Willson; Heidi R Flori
Journal:  Crit Care Med       Date:  2016-11       Impact factor: 7.598

9.  Diet-induced obesity alters vincristine pharmacokinetics in blood and tissues of mice.

Authors:  James W Behan; Vassilios I Avramis; Jason P Yun; Stan G Louie; Steven D Mittelman
Journal:  Pharmacol Res       Date:  2010-01-18       Impact factor: 7.658

10.  Anesthetic Pharmacology and the Morbidly Obese Patient.

Authors:  Jerry Ingrande; Hendrikus Jm Lemmens
Journal:  Curr Anesthesiol Rep       Date:  2012-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.